IRIS
ROGLIANI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 79.493
AS - Asia 13.451
EU - Europa 9.027
SA - Sud America 1.946
AF - Africa 174
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 24
Totale 104.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 79.091
SG - Singapore 6.255
CN - Cina 2.441
IT - Italia 1.851
BR - Brasile 1.608
RU - Federazione Russa 1.417
HK - Hong Kong 1.307
VN - Vietnam 1.094
IE - Irlanda 1.053
DE - Germania 884
UA - Ucraina 809
FR - Francia 752
KR - Corea 751
GB - Regno Unito 516
PL - Polonia 516
BD - Bangladesh 428
FI - Finlandia 395
JP - Giappone 370
SE - Svezia 253
CA - Canada 223
NL - Olanda 200
IN - India 169
ID - Indonesia 132
AR - Argentina 113
MX - Messico 89
ES - Italia 77
IQ - Iraq 73
AT - Austria 69
ZA - Sudafrica 58
PK - Pakistan 49
TR - Turchia 49
CO - Colombia 46
EC - Ecuador 44
AU - Australia 42
BE - Belgio 42
MY - Malesia 36
CL - Cile 35
VE - Venezuela 34
UZ - Uzbekistan 33
EG - Egitto 32
TW - Taiwan 32
PH - Filippine 29
PE - Perù 26
PT - Portogallo 24
SA - Arabia Saudita 24
AE - Emirati Arabi Uniti 21
RO - Romania 21
GR - Grecia 20
IL - Israele 20
PY - Paraguay 20
MA - Marocco 19
CZ - Repubblica Ceca 18
JO - Giordania 17
KE - Kenya 17
LT - Lituania 17
CR - Costa Rica 16
JM - Giamaica 16
TH - Thailandia 16
TN - Tunisia 16
AL - Albania 15
IR - Iran 12
NP - Nepal 12
UY - Uruguay 12
A2 - ???statistics.table.value.countryCode.A2??? 11
DZ - Algeria 10
EU - Europa 10
KZ - Kazakistan 10
BH - Bahrain 9
CH - Svizzera 9
DO - Repubblica Dominicana 9
PA - Panama 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
DK - Danimarca 8
KG - Kirghizistan 8
LB - Libano 8
NI - Nicaragua 8
AZ - Azerbaigian 7
ET - Etiopia 7
HR - Croazia 7
HU - Ungheria 6
KH - Cambogia 6
RS - Serbia 6
SV - El Salvador 6
BO - Bolivia 5
KW - Kuwait 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
LY - Libia 4
MK - Macedonia 4
OM - Oman 4
PR - Porto Rico 4
SI - Slovenia 4
CI - Costa d'Avorio 3
CY - Cipro 3
EE - Estonia 3
GT - Guatemala 3
Totale 104.112
Salva come PNG Salva come JPEG
Città #
Wilmington 19.879
Houston 18.376
Woodbridge 18.105
Fairfield 2.945
Singapore 2.894
Ashburn 1.937
San Jose 1.576
Ann Arbor 1.452
Hong Kong 1.279
Chandler 1.230
Seattle 1.195
Cambridge 955
Dublin 896
Beijing 770
Medford 685
Council Bluffs 569
New York 568
Jacksonville 563
Santa Clara 538
Rome 521
Dearborn 458
Kraków 456
The Dalles 433
Los Angeles 405
Ho Chi Minh City 356
Lawrence 318
Tokyo 318
Zhengzhou 282
Lauterbourg 274
Hanoi 257
Dallas 251
Moscow 227
Buffalo 219
Helsinki 200
San Diego 180
Boardman 172
Chicago 167
São Paulo 165
Monte Vista 137
Milan 130
Menlo Park 106
Colorado Springs 105
London 91
Jakarta 85
Shanghai 85
Naples 80
Redondo Beach 77
Hangzhou 75
Nuremberg 75
North Bergen 74
Phoenix 71
Toronto 68
Redwood City 63
Norwalk 62
Orem 58
Denver 56
Brooklyn 55
Guangzhou 53
Munich 53
San Francisco 49
Belo Horizonte 48
Rio de Janeiro 48
Warsaw 48
Montreal 47
Stockholm 47
Cardiff 46
Palo Alto 46
Frankfurt am Main 45
Columbus 43
Atlanta 42
Jinan 42
Nanjing 42
Salt Lake City 42
Haiphong 40
Da Nang 39
Hefei 39
Bar Harbor 38
Brussels 38
Poplar 38
Verona 38
Chennai 37
Mülheim 37
Dong Ket 35
Lappeenranta 35
Brasília 31
Johannesburg 31
Seoul 30
Manchester 29
Detroit 28
Falls Church 28
Mountain View 28
Tashkent 28
Amsterdam 27
Turin 27
Vienna 27
Baghdad 26
Boston 26
Curitiba 26
Kunming 26
La Veta 25
Totale 85.222
Salva come PNG Salva come JPEG
Nome #
Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules 550
β2-Agonist Therapy in Lung Disease 542
An update on the pharmacotherapeutic management of lower respiratory tract infections 528
Awake thoracoscopic biopsy of interstitial lung disease 523
Vats lung reduction in patients with advanced emphysema 522
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells 515
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 510
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 509
Interaction between corticosteroids and muscarinic antagonists in human airways 504
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 503
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 500
Minimalist video-assisted thoracic surgery biopsy of mediastinal tumors 500
Thoracoscopic reduction pneumoplasty for severe emphysema: Do pleural adhesions affect outcome? 498
Surgery of giant emphysematous bullae 492
Effect of lung volume reduction surgery for severe emphysema on right ventricular function 491
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 490
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 489
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 486
Completion lobectomy after bilateral lung volume reduction for emphysema: Salvage option or fancy? 485
An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network 485
Glucagon-like peptide 1 receptor: A novel pharmacological target for treating human bronchial hyperresponsiveness 485
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 485
Asthma and comorbid medical illness. 484
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 482
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. 481
Airflow obstruction: Is it asthma or is it COPD? 480
Optimizing drug delivery in COPD: The role of inhaler devices 480
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 479
Unilateral thoracoscopic reduction pneumoplasty for asymmetric emphysema 475
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation 475
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 471
Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement 469
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 469
Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase 467
High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. 466
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 464
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases 464
Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma 460
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab 460
Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules 459
Completion lobectomy after bilateral lung volume reduction for emphysema: salvage option or fancy? 459
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 459
Occupational allergy to horse allergens: More than exposure to horses! 458
Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease 455
Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: A point of view 453
The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators 453
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis 453
Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract 452
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease 451
Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? 449
Umeclidinium for the treatment of chronic obstructive pulmonary disease 448
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease 448
Results of unilateral lung volume reduction surgery in patients with distinct heterogeneity of emphysema between lungs 447
Can pet keeping be considered the only criterion of exposure to cat/dog allergens in the first year of life? 447
Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? 447
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients 446
Treatment options for moderate-to-very severe chronic obstructive pulmonary disease 446
Tiotropium formulations and safety: a network meta-analysis 446
Metabolic syndrome and risk of pulmonary involvement 445
Asthma and comorbid medical illness 441
Role of muscarinic antagonists in asthma therapy 440
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema 439
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 438
Bronchodilator therapy for chronic cough 438
Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD 436
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 434
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 434
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298 433
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease 433
QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease 433
How many systemic reactions to skin prick tests could be preventable in defined conditions? 433
Is allergic sensitization to siberian hamster preventable in high-risk individuals who are already sensitized or exposed to furry animals? 433
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 433
The Challenges of Precision Medicine in COPD 431
Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”? 431
Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study 430
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 430
Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis 430
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity. 429
New Treatments for COPD in the Elderly 429
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways 429
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? 429
Dog allergen immunotherapy and allergy to furry animals 427
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi 426
The effect of indacaterol during an acute exacerbation of COPD 424
Chronic treatment with indacaterol and airway response to salbutamol in stable COPD 424
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 424
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi 423
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD 422
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 422
Defining Phenotypes in COPD: An Aid to Personalized Healthcare 420
Translational study searching for synergy between glycopyrronium and indacaterol 420
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis 420
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 418
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 418
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 417
Bacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD. 417
Biomarkers of lung damage associated with tobacco smoke in induced sputum 417
Can the presence of cat/dog at home be considered the only criterion of exposure to cat/dog allergens? A likely underestimated bias in clinical practice and in large epidemiological studies 417
Comorbidities of asthma 416
Totale 45.677
Salva come PNG Salva come JPEG
Categoria #
all - tutte 283.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 283.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.246 202 278 87 73 105 322 422 149 182 301 279 846
2022/20233.538 466 250 122 394 271 903 321 208 316 36 161 90
2023/20241.769 353 46 131 37 128 376 110 200 59 69 31 229
2024/20259.740 297 1.970 989 476 313 424 805 526 885 1.022 1.061 972
2025/202616.318 1.088 931 1.735 1.276 1.618 664 2.081 1.941 2.042 1.141 1.076 725
2026/2027746 746 0 0 0 0 0 0 0 0 0 0 0
Totale 105.642